首页> 美国卫生研究院文献>BMJ Open >Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016

【2h】

Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016

机译：从制药公司到德国医疗保健专业人士的自愿披露：2015年和2016年披露的描述性研究

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

摘要
著录项
相似文献
相关主题

摘要

To analyse voluntary payment reports of pharmaceutical companies to German healthcare professionals (HCPs) in 2015 and 2016 based on an industry-self-regulating transparency codex.

机译：根据行业自控透明度法典分析2015年和2016年制药公司对德国医疗专业人士（HCP）的自愿支付报告。

著录项

期刊名称 BMJ Open
作者
Marlene Stoll; Lara Hubenschmid; Cora Koch; Klaus Lieb;
展开▼
作者单位

展开▼
年(卷),期 2020(10),9
年度 2020
页码 e037395
总页数 9
原文格式 PDF
正文语种
中图分类
关键词

机译：健康政策;卫生服务管理与管理;保健质量;

相似文献

外文文献
中文文献
专利

1. Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study [J] . Susan L Norris, Haley K Holmer, Lauren A Ogden, BMC Medical Ethics . 2012,第1期

机译：从制药公司收取大笔费用的医师的特征及其在出版物中披露的准确性：一项观察性研究
2. The Impact of Voluntary Disclosure on the Mandatory Disclosure of Financial Information: A Study of Companies on the Saudi Arabian Stock Exchange [J] . Christopher J. Robertson, Hussam A. Al-Angari, Sulaiman A. Al-AIsheikh International Journal of Management . 2012,第1pta2期

机译：自愿披露对财务信息强制披露的影响：沙特阿拉伯证券交易所公司研究
3. Evaluating the transparency of pharmaceutical company disclosure of payments to patient organisations in the UK [J] . Rickard Emily, Ozieranski Piotr, Mulinari Shai Health policy . 2019,第12期

机译：评估制药公司的透明度披露英国患者组织的付款
4. Study on status of voluntary carbon disclosure of China's listed companies: Based on Carbon Disclosure Project China reports [C] . Cui Yumeng, Song Yu International Conference on Service Systems and Service Management . 2016

机译：中国上市公司自愿性碳披露状况研究：基于碳披露项目中国报告
5. Competitive strategy, voluntary environmental disclosure strategy, and voluntary environmental disclosure quality. [D] . Ling, Qianhua. 2007

机译：竞争策略，自愿环境披露策略和自愿环境披露质量。
6. Disclosure of payments by pharmaceutical companies to healthcare professionals in the UK: analysis of the Association of the British Pharmaceutical Industry’s Disclosure UK database 2015 and 2016 cohorts [O] . Shai Mulinari, Piotr Ozieranski 2018

机译：英国制药公司向医疗保健专业人员的付款披露：2015年和2016年英国制药业披露英国数据库的分析
7. Characteristics of physicians receiving large payments from pharmaceutical companies and the accuracy of their disclosures in publications: an observational study [O] . Susan L Norris, Haley K Holmer, Lauren A Ogden, 2012

机译：从制药公司收取大笔费用的医师的特征及其在出版物中披露的准确性：一项观察性研究

Voluntary disclosures of payments from pharmaceutical companies to healthcare professionals in Germany: a descriptive study of disclosures in 2015 and 2016

摘要

著录项

相似文献

相关主题

期刊订阅